ARCT - Arcturus Therapeutics EPS misses by $0.72 misses on revenue November, 08 2021 04:45 PM Arcturus Therapeutics Ltd. Arcturus Therapeutics (NASDAQ:ARCT): Q3 GAAP EPS of -$2.05 misses by $0.72. Revenue of $2.44M (+6.1% Y/Y) misses by $16.76M. Shares +2%. Press Release For further details see: Arcturus Therapeutics EPS misses by $0.72, misses on revenue